GO:0008318 protein prenyltransferase activity: Mechanism, Genes

Protein prenyltransferase activity (GO:0008318) is a molecular function that catalyzes the covalent attachment of isoprenoid lipids, such as farnesyl or geranylgeranyl groups, to cysteine residues of target proteins via thioether bonds. This post-translational modification, known as protein prenylation, increases the hydrophobicity of proteins and facilitates their association with cellular membranes, which is critical for the biological activity of many signaling molecules. The enzymes responsible for this activity are collectively called protein prenyltransferases and include farnesyltransferase (FTase), geranylgeranyltransferase I (GGTase-I), and geranylgeranyltransferase II (GGTase-II or Rab GGTase). These enzymes recognize specific C-terminal motifs, such as the CAAX box, and transfer the isoprenoid moiety from a prenyl diphosphate donor to the cysteine thiol. Researchers study protein prenyltransferase activity because it regulates the localization and function of key proteins involved in cell growth, differentiation, and survival. For example, mutations in the RAS oncogene that alter prenylation can affect its membrane targeting and transforming potential. Moreover, altered prenyltransferase activity has been observed in spermatogenesis, schizophrenia, and cancer, making it a potential therapeutic target. Understanding the molecular mechanisms, regulation, and disease relevance of this activity is therefore of broad biomedical importance. In this article, we provide a comprehensive overview of GO:0008318, covering its definition, biological processes, cellular components, molecular mechanisms, key genes, regulation, disease associations, and research methods. We also highlight how CRISPR-based models can be used to investigate the function of prenyltransferases and their substrates.

Protein prenyltransferase activity (GO:0008318) is defined as the catalysis of the covalent addition of an isoprenoid group, such as a farnesyl or geranylgeranyl group, via a thioether linkage to a cysteine residue in a protein. This activity is a type of transferase activity, specifically transferring alkyl or aryl groups other than methyl groups. The reaction typically involves the nucleophilic attack of the cysteine thiolate on the prenyl diphosphate, releasing pyrophosphate and forming a thioether bond.

Protein prenyltransferase activity is crucial for the proper localization and function of a wide range of proteins, particularly small GTPases that regulate cell proliferation, differentiation, and survival. Dysregulation of this activity has been linked to cancer, where prenylation of oncogenic RAS is required for its membrane association and transforming activity. In addition, altered prenyltransferase expression has been observed in neuropsychiatric disorders such as schizophrenia, and in developmental processes like spermatogenesis. The essential role of prenyltransferases in these pathways makes them attractive targets for therapeutic intervention and highlights the need for robust research models.

The following genes encode the subunits of protein prenyltransferases and related processing enzymes, as well as representative substrate proteins.

Protein prenyltransferase activity is regulated at multiple levels. Expression of prenyltransferase subunits can be modulated by cellular signals and in disease states; for example, altered protein levels of prenyltransferase subunits have been observed in the dorsolateral prefrontal cortex of schizophrenia patients. The activity of cis-prenyltransferase complexes is subject to allosteric regulation, as revealed by structural studies showing conformational changes upon ligand binding. Additionally, the availability of isoprenoid donors (FPP and GGPP) from the mevalonate pathway influences prenyltransferase activity, and statins that inhibit HMG-CoA reductase can reduce prenylation. Phosphorylation and other post-translational modifications of prenyltransferases may also regulate their function, though specific mechanisms require further study.

Protein prenyltransferase activity is critical for the membrane localization and oncogenic function of RAS family GTPases, which are mutated in approximately 30% of human cancers. Farnesyltransferase inhibitors (FTIs) were developed to block RAS prenylation, but their clinical efficacy has been limited due to alternative prenylation by GGTase-I. Dual prenylation inhibitors and GGTase-I inhibitors are being explored as anticancer strategies. Additionally, prenyltransferase activity affects other oncogenic pathways, including Rho and Rac GTPases, which regulate cell migration, invasion, and metastasis.

Altered prenyltransferase activity has been implicated in schizophrenia, where protein expression of prenyltransferase subunits is changed in postmortem brain tissue. In neurodegenerative diseases such as Alzheimer's and Parkinson's, prenylation of small GTPases may affect neuronal survival and synaptic function. Furthermore, mutations in the lamin A gene (LMNA) that affect its prenylation cause laminopathies, including Hutchinson-Gilford progeria syndrome.

Protein prenyltransferase activity changes during spermatogenesis, with altered prenyltransferase activity observed in the rat seminiferous epithelium during early stages of spermatogenesis. This suggests a role in male fertility and germ cell development. Additionally, prenylation is essential for embryonic development, as knockout of prenyltransferase subunits in mice leads to embryonic lethality.

In vitro prenyltransferase assays typically use recombinant enzymes, a protein substrate (e.g., HRAS), and a radiolabeled or fluorescently labeled isoprenoid donor (FPP or GGPP). The incorporation of the isoprenoid into the protein is measured by scintillation counting, fluorescence polarization, or mass spectrometry. These assays are used to determine kinetic parameters, screen inhibitors, and study substrate specificity.

Prenylation in cells can be assessed by metabolic labeling with [3H]mevalonate or [3H]geranylgeraniol, followed by immunoprecipitation of the target protein and SDS-PAGE. Alternatively, prenylation can be detected by a shift in electrophoretic mobility or by using prenylation-specific antibodies. These methods are useful for studying the effects of inhibitors or genetic manipulations on prenylation in living cells.

X-ray crystallography and cryo-electron microscopy have been used to determine the structures of FTase, GGTase-I, and GGTase-II, revealing the active site architecture and allosteric regulation. Nuclear magnetic resonance (NMR) and isothermal titration calorimetry (ITC) can measure binding affinities of substrates and inhibitors. These techniques provide mechanistic insights into catalysis and guide drug design.

CRISPR-Cas9 knockout, point mutation, and knock-in models enable the study of prenyltransferase genes in a physiological context. RNA-seq and proteomics can be used to assess downstream effects on prenylation-dependent pathways. High-throughput screening with CRISPR libraries can identify genes that modulate sensitivity to prenyltransferase inhibitors.

Researchers studying protein prenyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell growth, neuronal function, or developmental processes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of prenyltransferases and their substrates.

Protein prenyltransferase activity (GO:0008318) is a fundamental molecular function that controls the membrane targeting and activity of numerous key signaling proteins. Its dysregulation contributes to cancer, neuropsychiatric disorders, and developmental defects, making it a critical area of biomedical research. Advances in structural biology, biochemical assays, and CRISPR-based genome editing are providing deeper insights into the mechanisms and regulation of prenyltransferases. EDITGENE offers a comprehensive portfolio of CRISPR services to support researchers in dissecting the roles of prenyltransferase genes and their substrates in health and disease.